BIMI International Medical Inc. Common Stock
BIMI
BIMI was delisted on the 21st of August, 2024.
5 hedge funds and large institutions have $8.17K invested in BIMI International Medical Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
29% less funds holding
Funds holding: 7 → 5 (-2)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
94% less capital invested
Capital invested by funds: $133K → $8.17K (-$125K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$73 |
| 2 |
JP Morgan Chase
New York
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$122K |
| 2 |
Renaissance Technologies
New York
|
-$7K |
| 3 |
N
Natixis
Paris,
France
|
-$795 |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$268 |
| 5 |
Morgan Stanley
New York
|
-$3 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
N
1
Natixis
Paris,
France
| $4.59K | -$795 | -864 | -20% |
|
|
2
UBS Group
Zurich,
Switzerland
| $3.48K | +$73 | +79 | +3% |
|
|
3
Osaic Holdings
Scottsdale,
Arizona
| $81 | -$268 | -291 | -83% |
|
|
FP
4
Financial Perspectives
Minneapolis,
Minnesota
| $11 | – | – | – |
|
|
5
JP Morgan Chase
New York
| $8 | +$6 | +6 | New |
|
|
6
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$122K | -223,000 | Closed |
|
|
7
Renaissance Technologies
New York
| – | -$7K | -12,500 | Closed |
|
|
8
Morgan Stanley
New York
| – | -$3 | -6 | Closed |
|
BIMI Hedge Fund Activity: Q2 2023 in Review
5 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q2 2023, worth a combined $8.17K — down 94% from $133K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BIMI and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $73. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $122K sold.
- 5 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q2 2023, down from 7 in Q1 2023.
- Funds reported $8.17K of BIMI International Medical Inc. Common Stock stock for Q2 2023, down 94% quarter-over-quarter.
- 1 fund opened new BIMI International Medical Inc. Common Stock positions in Q2 2023 and 3 closed out, a net change of -2 holders.
- The largest BIMI International Medical Inc. Common Stock buyer in Q2 2023 was UBS Group, an estimated $73 added.
- The largest BIMI International Medical Inc. Common Stock seller in Q2 2023 was Hudson Bay Capital Management, an estimated $122K sold.
Based on aggregated 13F filings for Q2 2023.